LourdesMMendezMDPhD

Hematology • New Haven, CT

Hematologic Oncology

Physician

Join to view full profile

Dr. Mendez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mendez's full profile

Already have an account?

Office
35 Park St
Smilow Cancer Hospital at Yale-New Haven
New Haven, CT 06519

Education & Training

Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2008 - 2011
Albert Einstein College of MedicineClass of 2008

Certifications & Licensure

CT State Medical License 2022 - 2025
MA State Medical License 2011 - 2023
NY State Medical License 2011 - 2013

Clinical Trials

Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid Leukemia Start of enrollment: 2018 Feb 08
Recruiting
Phase 1
Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia Start of enrollment: 2017 Sep 25
Completed
Phase 2
IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia Start of enrollment: 2019 Nov 06
Active, not recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

23 citations
Alisertib Plus Induction Chemotherapy in Previously Untreated Patients With High-Risk, Acute Myeloid Leukaemia: A Single-Arm, Phase 2 Trial
Andrew M. Brunner, Traci M. Blonquist, Daniel J. DeAngelo, Malgorzata McMasters, Geoffrey Fell
The Lancet. Haematology. 2020-02-01
203 citations
An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer
Ming Chen, Jiangwen Zhang, Katia Sampieri, John G. Clohessy, Lourdes M. Mendez
Nature Genetics. 2018-01-15
241 citations
Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas
B. Belinda Ding, J. Jessica Yu, Raymond Y L Yu, Lourdes M. Mendez, Rita Shaknovich
Blood. 2007-11-16

Press Mentions

Yale Study Finds That Small Molecule Can Increase White Blood Cell CountsFebruary 15th, 2024

Other Languages

Spanish